The TEAM Long-Term Cohort Study (A Sub-study of TEAM(III))
Long-term Evaluation of Disability and Quality of Life at 1,2 and 5 Years in Invasively Mechanically Ventilated Patients Who Received Early Activity and Mobilisation Compared to Standard Care.
1 other identifier
observational
250
1 country
16
Brief Summary
This study is a prospective cohort study to evaluate the long-term effects of early activity and mobilisation compared to standard care on disability, function and health status for patients at 1, 2 and 5 years after recruitment of patients randomised into the TEAM Phase III RCT (ClinicalTrials.gov NCT03133377). The primary outcome of the study will be the level of disability as measured by the World Health Organisation's Disability Schedule 2.0, 12 level (WHODAS) at 2 years after recruitment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
Longer than P75 for all trials
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 11, 2020
CompletedFirst Submitted
Initial submission to the registry
March 18, 2022
CompletedFirst Posted
Study publicly available on registry
March 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
ExpectedMarch 28, 2022
March 1, 2022
3.7 years
March 18, 2022
March 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Level of disability measured with the World Health Organisation's Disability Assessment Schedule (WHODAS) 2.0
level of disability as measured by the World Health Organisation's Disability Schedule 2.0, 2 level (WHODAS) at 2 years after recruitment.
Assessed 2 years after recruitment
Secondary Outcomes (21)
Time from randomisation until death
From date of randomisation until date of death from all cause, censored at 5 years
All-cause mortality
From date of randomisation to 1 year
All-cause mortality
From date of randomisation to 2 years
All-cause mortality
From date of randomisation to 5 years
Generic function and disability measured using World Health Organisation's Disability Assessment Schedule (WHODAS)
Assessed 1 year after recruitment
- +16 more secondary outcomes
Study Arms (2)
Intervention arm: TEAM protocol
Based on TEAM (III) protocol patients will be assessed daily by an ICU physiotherapist using the ICU Mobility Scale (IMS) to determine the dosage and type of active exercises the patient will receive, using the early activity and mobilisation protocol. This protocol is hierarchical, with the objective of each intervention session beginning with the highest level of activity possible for the longest time possible, which then steps down to lower levels of activity if the patient fatigues. The intervention will be administered on all days in which the patient is admitted to ICU during the index hospitalisation, censored at 28days after.
Standard of Care arm: TEAM protocol
Based on TEAM (III) protocol the control group will receive standard care from physiotherapy staff not involved in delivering the intervention. We have previously established that standard care in Australia for a patient receiving prolonged IMV (control group intervention) frequently involves no active exercise out of bed.
Interventions
The early activity and mobilisation intervention is comprised of exercises based on a reproducible, physiological approach using both strength and functional activities
Eligibility Criteria
Up to 380 critically ill adult Australian patients, who met all of the inclusion criteria and none of the exclusion criteria, as defined in the TEAM Phase III RCT and consent to follow-up.
You may qualify if:
- Enrolled in the TEAM Phase III RCT Protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (16)
Royal Prince Alfred Hospital
Camperdown, New South Wales, 2050, Australia
John Hunter Hospital
Sydney, New South Wales, Australia
Royal North Shore Hospital
Sydney, New South Wales, Australia
Wollongong Hospital
Wollongong, New South Wales, Australia
Sunshine Coast University Hospital
Birtinya, Queensland, Australia
Mater Health
Brisbane, Queensland, Australia
Mater Private Hospital
Brisbane, Queensland, Australia
Caboolture Hospital
Caboolture, Queensland, Australia
Redcliffe Hospital
Redcliffe, Queensland, 4020, Australia
Toowoomba Hospital
Toowoomba, Queensland, Australia
Launceston General Hospital
Launceston, Tasmania, Australia
Geelong Hospital - Barwon Health
Geelong, Victoria, 3220, Australia
Cabrini Hospital
Malvern, Victoria, 3144, Australia
Royal Melbourne Hospital
Parkville, Victoria, 3050, Australia
Alfred Hospital
Prahran, Victoria, 3004, Australia
Sunshine Hospital
St Albans, Victoria, 3021, Australia
Related Publications (6)
Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014 Apr 2;311(13):1308-16. doi: 10.1001/jama.2014.2637.
PMID: 24638143BACKGROUNDHerridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, Kudlow P, Cook D, Slutsky AS, Cheung AM; Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011 Apr 7;364(14):1293-304. doi: 10.1056/NEJMoa1011802.
PMID: 21470008BACKGROUNDTEAM Study Investigators; Hodgson C, Bellomo R, Berney S, Bailey M, Buhr H, Denehy L, Harrold M, Higgins A, Presneill J, Saxena M, Skinner E, Young P, Webb S. Early mobilization and recovery in mechanically ventilated patients in the ICU: a bi-national, multi-centre, prospective cohort study. Crit Care. 2015 Feb 26;19(1):81. doi: 10.1186/s13054-015-0765-4.
PMID: 25715872BACKGROUNDIwashyna TJ. Survivorship will be the defining challenge of critical care in the 21st century. Ann Intern Med. 2010 Aug 3;153(3):204-5. doi: 10.7326/0003-4819-153-3-201008030-00013. No abstract available.
PMID: 20679565BACKGROUNDIwashyna TJ, Netzer G. The burdens of survivorship: an approach to thinking about long-term outcomes after critical illness. Semin Respir Crit Care Med. 2012 Aug;33(4):327-38. doi: 10.1055/s-0032-1321982. Epub 2012 Aug 8.
PMID: 22875378BACKGROUNDHiggins AM, Pettila V, Harris AH, Bailey M, Lipman J, Seppelt IM, Webb SA. The critical care costs of the influenza A/H1N1 2009 pandemic in Australia and New Zealand. Anaesth Intensive Care. 2011 May;39(3):384-91. doi: 10.1177/0310057X1103900308.
PMID: 21675057BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Prof Carol Hodgson
ANZIC-RC
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2022
First Posted
March 28, 2022
Study Start
February 11, 2020
Primary Completion
November 1, 2023
Study Completion (Estimated)
November 1, 2026
Last Updated
March 28, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share